Abstract
Elasticity and bio-adhesiveness of circulating tumor cells (CTCs) are important biomarkers of cancer. CTCs are rare in blood, thus their capture and atomic force microscopy (AFM)-based biomechanical characterization require use of multifunctional microfluidic device. Here, we describe procedures for fabrication of such device, AFM-Chip, and give details on its use in affinity-based CTC capture, and integration with AFM via reversable physical assembly. In the AFM-Chip, CTC capture is efficient, and transition to AFM characterization is seamless with minimal cell loss. For complete details on the use and execution of this protocol, please refer to Deliorman et al. (2020).
| Original language | English |
|---|---|
| Article number | 101433 |
| Journal | STAR Protocols |
| Volume | 3 |
| Issue number | 2 |
| DOIs | |
| State | Published - 17 Jun 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Atomic Force Microscopy (AFM)
- Biotechnology and bioengineering
- Cell isolation
- Single Cell
Fingerprint
Dive into the research topics of 'Characterizing circulating tumor cells using affinity-based microfluidic capture and AFM-based biomechanics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver